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Introduction 
Dengue is one of the most geographically significant mosquito-
transmitted diseases caused by dengue virus (DENV). In endemic 
areas of tropics and subtropics, this disease has become the leading 
cause of morbidity and mortality. In the Americas, DENV is primarily 
transmitted to humans by Aedes aegypti and Ae. albopictus 
mosquitoes. During blood feeding, the female mosquito injects saliva 
into the human skin to facilitate meal intake. The salivary proteins 
(mSP) stimulate immune responses that may lead to antibody 
production and modulation of cellular and cytokine function with a 
strong effect on viral infectivity. Previous studies have showed that 
the salivary allergen D7 exhibits anti-viral properties for DENV in the 
human skin. It is hypothesized  that in endemic settings, after 
repeated exposure to mosquito bites, human hosts develop an 
immune response against mSP that can enhance or block viral 
infectivity.  
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Questions, Hypotheses, and Predictions 
Question: What are the levels of antibody response against a D7 
salivary proteins in healthy individuals from Kansas? 
Hypothesis: The antibody response against Ae. aegypti saliva is 
directly correlated with the level of exposure to mosquito bites. 
Prediction: People engaged in outdoor activities with no use of 
protective strategies such as repellent will present higher antibody 
levels against Ae. aegypti D7 proteins than people using repellent or 
staying indoors during vacations. 
Study System 
We designed two peptides from the D7 long salivary protein from Ae. 
aegypti mosquitoes. These peptides contain 18 (D7L1) and 21 
(D7L2) aminoacids. The peptides where used as antigen in an ELISA 
test to measure IgG, IgM and IgE antibodies from human blood. 
Methods and Experimental Design 
Results 
We enrolled 13 healthy volunteers (7 females and 8 men) living in Manhattan, 
KS, with ages between 19 and 42 years old (mean age = 24.08). The average 
time residing in the city was 3.3 semesters (calculated based on the number of 
semesters attending KSU). All participants were engaged in any type of outdoor 
activity (i,e. gardening, hiking, camping); however, only 7 out of 13 (54.9%) 
reported the use of repellent.  
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Figure 1: Correlation between participants age 
and levels of IgE. 
We found a significant negative correlation 
between age and D7L2; which means that the 
older the person the lower the level of IgE 
antibodies against D7.  
Figure 2: IgG levels of antibodies in in relation 
with the use of repellent among the participants. 
When we compared the levels of antibodies 
against each protein, we found that higher IgG 
antibodies are associate with the no-use of use 
repellent.  
Figure 3: Antibody levels of IgG (A), IgM (B), IgE (C) in males and females. 
We compared level of exposure and response in males versus females and found that IgG 
antibodies against D7L1 were significantly higher in females (A) as well as IgM antibody 
levels for both D7L1 and D7L2 (B). We did not find significant differences between males 
and females for IgE antibodies.  
Purpose 
We attempt to establish whether people residing in non-endemic 
areas for DENV develop antibodies against D7 salivary proteins. 
These findings will help to understanding host–mosquito interaction in 
the absence of the disease. 
Conclusions 
Mosquito saliva plays an important role in vector-borne 
disease transmission and pathology. Here we show that IgG 
antibody levels against D7 salivary proteins are higher in 
people that does not use repellent, which suggest that D7 
proteins might be useful markers to measure human–
mosquitoes contact. We also found that males and females 
respond differently to mosquito salivary antigens. Our 
results may have implications for pathogen transmission 
and presentation of clinical disease. Since mSP have a 
profound impact on pathogen transmission, additional 
studies characterizing factors that may influence immune 
response against salivary proteins are needed. 
